Recruiting

Observational Study

Sponsor:

Alport Syndrome Foundation

Code:

NCT06526741

Conditions

Alport Syndrome

Thin Basement Membrane Disease

Hereditary Nephritis

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Longitudinal data collection

Study Details

Brief summary:

Alport Syndrome Foundation's (ASF's) Alport Patient Registry (the Registry) is open to individuals living with Alport syndrome in the United States (US) and US territories and outlying islands. The Registry welcomes participants of all ages who have a confirmed clinical diagnosis of Alport syndrome. A confirmed diagnosis could be obtained via genetic testing, biopsy, and/or from a medical professional's clinical assessment of the individual's symptoms and/or family history. Participants can have any form and stage of this disease to be eligible for inclusion in the Registry.

Patient participation in the Registry is crucial to helping attract and advance research, understanding understudied aspects of the disease, and informing clinical trials that may lead to Alport syndrome therapies and/or a cure.

The Registry is accessed through a secure, online application. Participants report their own health history in the Registry and are encouraged to update any changes, at most, every three months.

The security of each participant's information is a top priority. Any detail that could identify an individual participant is kept confidential in the Registry and such data are de-identified to protect the participant's privacy. No electronic health records or social security numbers are requested by or connected to the Registry.

A parent or legal guardian may consent to enroll a child/dren Alport patient(s) under the age of 18 years. An additional assent form is used for individuals ages 7-17. At age 18, participants will be required to re-consent as an adult if they choose to continue to participate in the Registry.

Conditions

Alport Syndrome

Thin Basement Membrane Disease

Hereditary Nephritis

Study ID

NCT06526741

Start date

Aug 24, 2023

Status verified date

Apr, 2026

Completion date

Aug 23, 2048

Anticipated

Primary completion date

Aug 23, 2048

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Confirmed diagnosis of Alport syndrome by a certified genetic counselor, treating physician or nephrologist.
2. Signed informed consent/assent must be provided by the subject and/or caregiver (parent/legal guardian) including compliance with the restrictions listed in the informed consent/assent form and in the study protocol. (Separate age-appropriate assent forms are provided for ages 7-12 years and ages 13-17 years.)
3. Must reside in the USA or US territories and outlying islands. (This criterium may change at an as-yet undetermined future date.)

Exclusion Criteria:

\[none\]

Study Design

Enrollment

2500 participants

Anticipated

Interventions and Outcome Measures

Arms

Alport syndrome patients

Patients with a confirmed diagnosis of Alport syndrome by a certified genetic counselor, treating physician, or nephrologist.

Interventions

Longitudinal data collection

This is an observational ambispective non-interventional registry collecting longitudinal real-world data only. There is no intervention.

Primary outcome measure

  • Total number of enrolled participants [ Time Frame: 5 years ]

Central Contacts and Locations

Locations

On-line only: https://asfalportpatientregistry.healthie.net

Recruiting

Scottsdale, Arizona, United States, 85261

Contacts

Principal Investigator:

Makabe Aberle, BS

More Information

Sponsor

Alport Syndrome Foundation

Last update posted

Apr 14, 2026

Last verified

Apr, 2026

Keywords

  • Alport
  • COL4A3
  • COL4A4
  • COL4A5
  • Collagen Type-IV
  • Glomerulonephropathy
  • Glomerulosclerosis
  • Genetic Kidney Disease

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-26. This information was provided to ClinicalTrials.gov by Alport Syndrome Foundation on 2026-04-14. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.